Compass Diversified Holdings (NYSE:CODI) filed its quarterly report on Form 10-Q for the period ended September 30, 2026, with the SEC on November 4, 2026, disclosing the final wind-down of its Lugano subsidiary and continued impacts from an internal investigation launched in April 2025.
TKO Group Holdings, Inc. filed its Form 10-Q with the U.S. Securities and Exchange Commission on November 4, 2026, covering the quarterly period ended September 30, 2026.
TKO Group Holdings, Inc. filed a current report on November 4, 2026, announcing its financial results for the quarterly period ended September 30, 2026, and providing supplemental historical financial information related to recent acquisitions treated as mergers of entities under common control.
Andrew M. Schleimer, Chief Financial Officer of TKO Group Holdings, Inc., filed a Form 4 on November 4, 2026, disclosing the acquisition of 56,780 restricted stock units on November 2, 2026, granted as an upfront award under an amendment to his term employment agreement.
Abbott Laboratories filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 4, 2026, reporting third-quarter net sales of $13.013 billion and net earnings of $920 million.
AdvanSix Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 4, 2026, reporting a net loss for both the third quarter and the first nine months of the year.
Madison Square Garden Entertainment Corp. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the Securities and Exchange Commission on November 4, 2026, reporting a swing to net income from a net loss in the prior-year quarter.
Sera Prognostics, Inc. filed its quarterly report on Form 10-Q with the SEC on November 4, 2026, covering the fiscal quarter ended September 30, 2026, disclosing condensed financial statements and operational updates for the period.
Sunrun Inc. officer Maria Barak filed a Form 144 notice on November 4, 2026, disclosing a proposed sale of 3,256 shares of Sunrun common stock on NASDAQ, with an aggregate market value of $30,444.00.
Merck & Co., Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 4, 2026, reporting a third-quarter net income of $5.065 billion alongside a nine-month net loss attributable to the company …